Dextran Retention in the Rat Brain Following Release from a Polymer Implant
Citations Over Time
Abstract
Intracranial controlled release polymers may improve drug administration to the brain, where therapy is frequently limited due to the low permeability of brain capillaries to therapeutic agents. On the basis of drug transport and elimination rates, we proposed that high molecular weight, water-soluble molecules would be retained in the brain space following release from an intracranial implant. To test this hypothesis, solid particles of different molecular weight fractions of fluorescein isothiocyanate labeled dextran (FITC-dextran; 4 x 10(3) Da (4 kDa) > 4 kDa Mw FITC-dextran > fluorescein). The rate of elimination, kapp, of each tracer from the brain was determined by comparing experimental data with a model describing tracer diffusion/elimination in the brain extracellular space; kapp decreased with increasing molecular weight (fluorescein > 4 kDa Mw FITC-dextran > 70 kDa Mw FITC-dextran).
Related Papers
- → The Manufacture and Tumour Cell Uptake of Nanoparticles Labelled with Fluorescein Isothiocyanate(1979)34 cited
- → Conjugation of Antibodies to Fluorescein or Rhodamine(2005)17 cited
- → Studies on the synthesis of fluorescein-5-isothiocyanate: A fluorescent nanomarker for biosensors(2015)6 cited
- → Stability of fluorescein labeled dextrans in vivo and in vitro(1976)73 cited
- → Multiple Releasable Fluorescein Labels for Immunoassay: The Principle Illustrated by an Immunoassay for Antibodies to the Human Immunodeficiency Virus(1991)5 cited